Boylan James P bought ZBIO

June 10, 2025 · Form 4 insider transaction

Boylan James P bought 18,500 shares of Zenas BioPharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
18,500
Price
$0.00
Total value
N/A
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 10, 2025
Filing dateJune 12, 2025
Shares owned after18,500
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The option vests as to 100% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, subject to continued service.; The reporting person holds the stock option, and the shares underlying the option, for the benefit of Enavate Sciences, LP. Accordingly, the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, if any.

View the original Form 4 on SEC EDGAR